Software Development
San Francisco, California
2-10 employees
Founded 2024
About ReSync Bio
ReSync Bio is dedicated to accelerating drug discovery by providing biopharmaceutical companies and their research teams with a no-code, AI-powered platform. The ReSync Platform offers scientists seamless access to advanced AI tools, automating data and operations to move from idea to insight faster. This enables users to conduct large-scale in-silico analysis across the entire discovery lifecycle without building or managing complex AI infrastructure.
Company Classification
Customer Types
B2B
Business Models
Subscription
Product & Service Types
AI Drug Discovery PlatformNo-Code Scientific Software
Funding
No. of Funding Rounds
1
Customers
| Customer | Success Story | Source |
|---|---|---|
| Utilized ReSync Bio's advanced AI tools to enhance drug discovery processes. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos